RET and medullary thyroid gland carcinoma: To determine if Vandetanib has stronger anti-proliferative effects in MTC cells harboring RET mutations, we compared the dose-dependent effects of Vandetanib on sporadic (MTC-SK) and familial (TT) MTC cell lines (Figure 3B).